424B4
priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2026-01-30 · 0001193125-26-029993
CERT
inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows 8-A12B in the pre-IPO sequence.
2026-01-28 · 0001354457-26-000102
EFFECT
effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows CERT and marks the registration effective.
2026-01-28 · 9999999995-26-000323
8-A12B
effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows S-1/A and registers the class of securities for exchange listing.
2026-01-21 · 0001193125-26-018153
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2026-01-20 · 0001193125-26-015943
S-1/A
amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2025-12-05 · 0001193125-25-309928
S-1
filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
Ethos Technologies Inc. is conducting an initial public offering (IPO) of its Class A common stock, with an estimated price range of $X.XX to $X.XX per share. The company aims to list on Nasdaq under the symbol 'LIFE'. The offering includes shares from the company and selling stockholders, with no proceeds going to Ethos from the latter. The filing highlights Ethos' mission to democratize life insurance access through a technology platform, serving consumers, agents, and carriers. Financials show strong growth, with LTM revenue of $320M, 57% YoY growth, and a 19% net margin. The company is an emerging growth entity with significant voting control by founders and major investors.
2025-09-26 · 0001193125-25-219975
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
Ethos Technologies Inc. is preparing for its initial public offering (IPO) of Class A common stock, with the filing serving as Amendment No. 2 to its draft registration statement. The offering remains confidential, with no public filing yet. The company aims to list on a stock exchange under the symbol 'LIFE' and has two classes of common stock with differing voting rights. As an emerging growth company, it benefits from reduced reporting requirements. The filing outlines key financial terms, underwriting details, and risk factors, though specific pricing and exchange details are pending.
2025-08-27 · 0000950123-25-008597
DRS/A
amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
Ethos Technologies Inc. is conducting an initial public offering (IPO) of its Class A common stock, with an estimated price range and planned listing on a specified exchange. The company, an emerging growth company, operates a technology platform connecting consumers, agents, and carriers in the life insurance market. The filing includes details on share structure, voting rights, and underwriting terms, with a focus on risks related to market competition, policy terminations, and regulatory compliance.
2025-07-30 · 0000950123-25-006749
DRS
filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
Ethos Technologies Inc. is registering an initial public offering (IPO) of its Class A common stock under Form S-1. The filing marks the company's first public offering, with no prior filings. The company operates a technology platform connecting consumers, agents, and carriers in the life insurance market. It has two classes of common stock with differing voting rights and is classified as an emerging growth company, electing reduced reporting requirements. The IPO price range and listing exchange details are pending, with underwriters including Goldman Sachs and J.P. Morgan.
2025-06-12 · 0000950123-25-006002